AMERISE BIOSCIENCES LIMITED

Capital Goods · Industrial Products

BSE: 531681
₹0.81
▼ -0.04 (-4.71%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
67/100
Moderate
Valuation
100/100
Undervalued
Momentum
33/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹5 Cr
PE (TTM)
Data unavailable.
Price to Book
1.0
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-31.4
Free Cash Flow
₹-1 Cr
as of March 31, 2026
Industry median ₹-0 Cr (379 companies)
EPS Growth (YoY)
-50.00%
as of March 31, 2026
Industry median 18.18% (314 companies)
Net Profit Growth (TTM)
-210.42%
as of June 30, 2026
Industry median 12.01% (310 companies)
Operating Revenue Growth (TTM)
-20.36%
as of June 30, 2026
Industry median 8.28% (307 companies)
Profit Growth (YoY)
-925.00%
as of June 30, 2026
Industry median 15.23% (307 companies)
Revenue Growth (YoY)
-57.98%
as of March 31, 2026
Industry median 16.28% (288 companies)
Current Ratio
0.30
as of March 31, 2026
Industry median 2.00 (375 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.15 (334 companies)
Interest Coverage
134.33
as of Sept. 30, 2025
Industry median 6.34 (319 companies)
Net Margin
77.22%
as of March 31, 2026
Industry median 5.55% (300 companies)
Operating Margin (EBIT)
77.22%
as of March 31, 2026
Industry median 9.14% (306 companies)
Operating Margin (TTM)
-0.77%
as of June 30, 2026
Industry median 8.26% (317 companies)
Return on Assets
0.28%
as of March 31, 2026
Industry median 4.65% (315 companies)
Return on Capital Employed
0.39%
as of March 31, 2026
Industry median 11.69% (315 companies)
Return on Equity
0.39%
as of March 31, 2026
Industry median 8.58% (315 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (0.4%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

1 of 1 met
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-4.7%
Low 0.8100 · High 0.8500
1W return
1.3%
Low 0.7900 · High 0.8500
1M return
1.3%
Low 0.7700 · High 0.8600
52W return
-38.6%
Low 0.7700 · High 0.9100
Lifetime High ₹30.0000 (Oct. 3, 2008)
Lifetime Low ₹0.5400 (Oct. 23, 2023)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish3
5D
0.8
10D
0.8
20D
0.8
50D
0.8
100D
0.8
200D
0.7

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

0.82
Pivot
First resistance0.84
Second resistance0.86
Third resistance0.88
First support0.80
Second support0.78
Third support0.76
Day RSI49.1
Day MFI56.4
Day MACD0.00
Day MACD signal0.00

Beta

1M0.28
3M-0.23
1Y-0.23
3Y0.65

Price change analysis

↑ 1.3%
Over 1 Month
LowHigh
0.770.86
↓ -38.6%
Over 3 Months
LowHigh
0.770.91
↓ -38.6%
Over 6 Months
LowHigh
0.770.91
↓ -38.6%
Over 1 Year
LowHigh
0.770.91
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹— Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹-0.0100

Ranks #325 of 335 in Industrial Products by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Data unavailable.

Full shareholding pattern →

DateClientDealActionQuantityPriceExchange
15 Jul 2026 SNEHA SANJEEV LUNKAD Bulk Sell 417,285 0.9500 BSE
23 Apr 2026 TINIBEN SURESHBHAI DARJI Bulk Sell 350,222 0.7700 BSE
23 Apr 2026 SNEHJEEV VENTURES PRIVATE LIMITED Bulk Buy 370,000 0.7700 BSE
4 Feb 2026 SNEHA SANJEEV LUNKAD Bulk Sell 351,561 0.7800 BSE
4 Feb 2026 KANCHAN PATHAK Bulk Buy 500,000 0.7800 BSE
17 Oct 2025 RUBEENAMAHBOOBGAURI Bulk Sell 489,816 0.5700 BSE
8 Jan 2025 DIPAKKUMARGAUTAM Bulk Sell 380,933 1.1900 BSE
12 Nov 2024 SARDAR SINGH RANWA Bulk Buy 367,619 1.0500 BSE
3 Jul 2023 SULEKHA RANI Bulk Buy 108 0.7400 BSE
3 Jul 2023 SULEKHA RANI Bulk Sell 413,202 0.7500 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Amradeep Industries Ltd. to AMERISE BIOSCIENCES LIMITED
—NAME_CHANGEName changed from Amstar Laminates Ltd. to Amradeep Industries Ltd.

All corporate actions →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Sep 2026 Corp. Action Amerise Biosciences Ltd - 531681 - Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (77.2%)
  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (134.3x)

Weaknesses

  • Low Return on Equity (0.4%)
  • Tight liquidity (Current Ratio 0.30)
  • Declining revenue YoY (-58.0%)
  • Declining profit YoY (-925.0%)

Opportunities

  • Trading below book value (PB 0.99)

Threats

  • Down 38.6% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about AMERISE BIOSCIENCES LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.